Pediatric Blood & Cancer

Article	Citations
Osteosarcoma	103
Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experience	80
COVID‐19 and children with cancer: Parents’ experiences, anxieties and support needs	75
Neuroblastoma	67
Hematological manifestations of SARS‐CoV‐2 in children	57
The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis	53
Clinical presentations and outcomes of children with cancer and COVID‐19: A systematic review	46
2023 ASPHO Conference Paper and Poster Index	46
Impacts of COVID‐19 on caregivers of childhood cancer survivors	45
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials	44
Single‐center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia	43
Ewing sarcoma	42
ABSTRACTS	41
Wilms tumor	39
A collateral effect of the COVID‐19 pandemic: Delayed diagnosis in pediatric solid tumors	39
Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studi	37
A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups	36
Late effects of radiation therapy in pediatric patients and survivorship	36
Safety of administration of BNT162b2 mRNA (Pfizer‐BioNTech) COVID‐19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG‐asparaginase	34
Children and young adults hospitalized for severe COVID‐19 exhibit thrombotic coagulopathy	34
Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS‐CoV‐2 pandemic	33
ABSTRACTS	33
No increase in psychosocial stress of Dutch children with cancer and their caregivers during the first months of the COVID‐19 pandemic	33
ORAL ABSTRACTS	32
Convalescent plasma for pediatric patients with SARS‐CoV‐2‐associated acute respiratory distress syndrome	32

Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial	31
SIOP ABSTRACTS	31
Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B‐acute lymphoblastic leukemia	31
A prospective study on the long‐term outcome of prepubertal and pubertal boys undergoing testicular biopsy for fertility preservation prior to hematologic stem cell transplantation	30
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high‐risk neuroblastoma: An International Neuroblastoma Risk Group project	30
Sarcopenia is a prognostic outcome marker in children with high‐risk hepatoblastoma	28
Are children with SARS‐CoV‐2 infection at high risk for thrombosis? Viscoelastic testing and coagulation profiles in a case series of pediatric patients	28
Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001	28
Severe adverse events during sirolimus “off‐label” therapy for vascular anomalies	28
COVID‐19 in pediatric cancer patients in a resource‐limited setting: National data from Peru	27
Acute lymphoblastic leukemia	27
How we approach the diagnosis and management of complex lymphatic anomalies	26
VEGFR2 as a target for CAR T cell therapy of Ewing sarcoma	26
Second tumor risk in children treated with proton therapy	25
Tools to guide the identification and implementation of care consistent with the psychosocial Standards of care	25
How we approach thrombosis risk in children with COVID‐19 infection and MIS‐C	25
The gut microbiome in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation	25
PediCARE: Development of a poverty‐targeted intervention for pediatric cancer	25
SIOP ABSTRACTS	25
Frequency of face touching with and without a mask in pediatric hematology/oncology health care professionals	24
Long‐term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study	24
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC‐042)	24
Long‐term health‐related quality of life in young childhood cancer survivors and their parents	23
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years	23
Sickle cell disease and COVID‐19: Susceptibility and severity	23
Homestead together: Pediatric palliative care telehealth support for rural children with cancer during home‐based end‐of‐life care	23
Naxitamab combined with granulocyte‐macrophage colony‐stimulating factor as consolidation for high‐risk neuroblastoma patients in complete remission	22
Guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group	22
Epidemiology and survival of childhood cancer in Turkey	21
Administrative data identify sickle cell disease: A critical review of approaches in U.S. health services research	21
Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience	21
Clinical prognostic factors in pediatric adrenocortical tumors: A meta‐analysis	20
Long‐term cognitive and academic outcomes among pediatric brain tumor survivors treated with proton versus photon radiotherapy	20
The role of interferon‐gamma and its signaling pathway in pediatric hematological disorders	20
Surgical management of paratesticular rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, European paediatric Soft tissue sarcoma Study Group, and the Cooperative Weichteilsarkom	20
Primary caregiver decision‐making in hematopoietic cell transplantation and gene therapy for sickle cell disease	20
Delayed presentations of pediatric solid tumors at a tertiary care hospital in the Bronx due to COVID‐19	20
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low‐grade glioma	20
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group	20
COVID‐19 infection in children with cancer and stem cell transplant recipients in Turkey: A nationwide study	20
Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces blood angiopoietin‐2 levels	19
Household material hardships impact emergency department reliance in pediatric patients with sickle cell disease	19
Rhabdomyosarcoma	19
Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?	19
Social determinants of health and pediatric cancer survival: A systematic review	19
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pedia	19
Virtual visits as long‐term follow‐up care for childhood cancer survivors: Patient and provider satisfaction during the COVID‐19 pandemic	19
Incidence and 5‐year survival of children and adolescents with hepatoblastoma in the United States	19
FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma	19
Undifferentiated sarcoma of the liver: Multicenter international experience of the Cooperative Soft‐Tissue Sarcoma Group and Polish Paediatric Solid Tumor Group	19

A randomized controlled trial of a structured exercise intervention after the completion of acute cancer treatment in adolescents and young adults	19
Treatment of acute myeloid leukemia in children: A practical perspective	18
Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations	18
Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B‐cell acute lymphoblastic leukemia	18
A safety and feasibility trial of 131I‐MIBG in newly diagnosed high‐risk neuroblastoma: A Children's Oncology Group study	18
Discrepancies between F‐18‐FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis	18
Care experiences that foster trust between parents and physicians of children with cancer	18
Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline	18
Impact of COVID‐19 on adolescent and emerging adult brain tumor survivors and their parents	18
18F‐FDG PET and PET/CT as a diagnostic method for Ewing sarcoma: A systematic review and meta‐analysis	18
Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft‐Tissue Sarcoma Group, and the Cooperative Weichteilsarkom Studie	17
Much is left unspoken: Self‐reports from families in pediatric oncology	17
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune‐suppressive therapy for newly diagnosed	17
Assessment of nutritional status in children with cancer: Significance of arm anthropometry and serum visceral proteins	17
Ruxolitinib in children with steroid‐refractory acute graft‐versus‐host disease: A retrospective multicenter study of the pediatric group of SFGM‐TC	17
Sickle cell disease and social determinants of health: A scoping review	17
Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross‐sectional analysis of personal payments from pharmaceutical co	17
A phase 1 study of entinostat in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1513, Pediatric Early Phase‐Clinical Trial Network (PEP‐CTN)	17
A community‐based trial of a psychosocial eHealth intervention for parents of children with cancer	17
Implementation of daily patient‐reported outcome measurements to support children with cancer	17
COVID‐19 infection in febrile neutropenic pediatric hematology oncology patients	17
Pancreaticoduodenectomy for the treatment of pancreatic neoplasms in children: A Pediatric Surgical Oncology Research Collaborative study	17
Introducing INSTRuCT: An international effort to promote cooperation and data sharing	17
Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab	16
The role of twinning in sustainable care for children with cancer: A TIPPing point? SIOP PODC Working Group on Twinning, Collaboration, and Support	16
Pediatric classical Hodgkin lymphoma	16
Treatment abandonment: A report from the collaborative African network for childhood cancer care and research—CANCaRe Africa	16
Treatment of central giant cell granuloma in children with denosumab	16
A review of the experience with pediatric written requests issued for oncology drug products	16
A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high‐risk pediatric patients	16
Clinical outcomes and quality of life in children and adolescents with primary brain tumors treated with pencil beam scanning proton therapy	16
Interdependent functions of communication with adolescents and young adults in oncology	16
“Money was the problem”: Caregivers' self‐reported reasons for abandoning their children's cancer treatment in southwest Uganda	15
L‐leucine improves anemia and growth in patients with transfusion‐dependent Diamond‐Blackfan anemia: Results from a multicenter pilot phase I/II study from the Diamond‐Blackfan Anemia Registry	15
Wilms tumor in Africa: A systematic review of management challenges and outcome in two decades (2000‐2019)	15
Eltrombopag in children with severe aplastic anemia	15
Acute chest syndrome in the setting of SARS‐COV‐2 infections—A case series at an urban medical center in the Bronx	15
Severe COVID‐19 disease in two pediatric oncology patients	15
Effects of hydroxyurea on brain function in children with sickle cell anemia	15
In vivo evaluation of the lysine‐specific demethylase (KDM1A/LSD1) inhibitor SP‐2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consor	15
Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study	15
Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic review	15
Safety and efficacy of gamma‐secretase inhibitor nirogacestat (PF‐03084014) in desmoid tumor: Report of four pediatric/young adult cases	15
A Saudi family with sickle cell disease presented with acute crises and COVID‐19 infection	15
Radiogenomics prediction for MYCN amplification in neuroblastoma: A hypothesis generating study	15
Prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update	15
Recognizing and managing hereditary and acquired thrombotic thrombocytopenic purpura in infants and children	14
How we approach malignant infantile osteopetrosis	14
Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents	14
Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned	14
Family functioning and adaptation following pediatric brain tumor: A systematic review	14
Autoimmune cytopenias following allogeneic hematopoietic stem cell transplant in pediatric patients: Response to therapy and late effects	14
The state of the science for communication training in pediatric oncology: A systematic review	14
Defining palliative opportunities in pediatric patients with bone and soft tissue sarcomas	14
Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescent	14
Clinical, pathologic, and molecular features of inflammatory myofibroblastic tumors in children and adolescents	14
Pseudohypoxic pheochromocytomas and paragangliomas dominate in children	14
Racial and ethnic disparities in survival of children with brain and central nervous tumors in the United States	14
Palliative care considerations and practices for adolescents and young adults with cancer	14
“Living life as if I never had cancer”: A study of the meaning of living well in adolescents and young adults who have experienced cancer	14
Factors affecting COVID‐19 vaccine hesitancy in parents of children with cancer	14
How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group	14
Childhood cancer survivorship and late effects: The landscape in India in 2020	13
Acute lymphoblastic leukemia onset in a 3‐year‐old child with COVID‐19	13
Psychological adjustment outcomes among pediatric brain tumor survivors: A meta‐analysis	13
Comparison of neuropsychological functioning in pediatric posterior fossa tumor survivors: Medulloblastoma, low‐grade astrocytoma, and healthy controls	13
The annual incidence of Langerhans cell histiocytosis among adults living in Greece	13
Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib	13
Different 18F‐FDG PET parameters for the prediction of histological response to neoadjuvant chemotherapy in pediatric Ewing sarcoma family of tumors	13
A pilot study of the preliminary efficacy of Pain Buddy: A novel intervention for the management of children's cancer‐related pain	13
Cranial polyneuropathy as the first manifestation of a severe COVID‐19 in a child	13
Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium	13
COVID‐19 and childhood acute lymphoblastic leukemia	13
SARS‐CoV‐2 in children with cancer in Brazil: Results of a multicenter national registry	13
Clinical impact of hypothalamic‐pituitary disorders after conformal radiation therapy for pediatric low‐grade glioma or ependymoma	13
Long‐term results from the multicentric European randomized phase 3 trial CWS/RMS‐96 for localized high‐risk soft tissue sarcoma in children, adolescents, and young adults	13
Citrulline as a biomarker of bacteraemia during induction treatment for childhood acute lymphoblastic leukaemia	13
Prospective randomized trial of interventions for vincristine‐related neuropathic pain	13
Evaluation of the nephron‐sparing surgery formula in Wilms tumors	13
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups	13

Abstracts for PBC Volume 67, Supplement 5	13
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate‐risk Hodgkin lymphoma treated with chemo‐radiation therapy: FDG‐PET parameter analysis in a subgroup f	13
Pilot study of the combination of sorafenib and fractionated irinotecan in pediatric relapse/refractory hepatic cancer (FINEX pilot study)	12
High mortality of COVID‐19 in children with cancer in a single center in Algiers, Algeria	12
Hematological parameters and peripheral blood morphologic abnormalities in children with COVID‐19	12
Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective	12
Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, the European Pediatric Soft‐Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom S	12
Genetic factors involved in delayed methotrexate elimination in children with acute lymphoblastic leukemia	12
Radiologic response to MEK inhibition in a patient with a WNT‐activated craniopharyngioma	12
Interventions to improve early detection of childhood cancer in low‐ and middle‐income countries: A systematic review	12
Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6‐mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestina	12
Practice patterns and recommendations for pediatric image‐guided radiotherapy: A Children's Oncology Group report	12
Clinicopathological study of surgery for pulmonary metastases of hepatoblastoma with indocyanine green fluorescent imaging	12
Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10‐year review	12
Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia	12
Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response	12
Oral processing speed as a key mechanism in the relationship between neurological risk and adaptive functioning in survivors of pediatric brain tumors	12
Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations	12
Acceptability and feasibility of survivorship care plans and an accompanying mobile health intervention for adolescent and young adult survivors of childhood cancer	12
The use of interval‐compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor	12
Outcomes in children with hemophilia A with inhibitors: Results from a noninterventional study	12
Pediatric and young adult renal cell carcinoma	12
Current approaches to management of bone sarcoma in adolescent and young adult patients	12
Children with cancer during COVID‐19 pandemic: Early experience in Mexico	11
Post‐COVID‐19 severe neutropenia	11
The intersectionality of gender and poverty on symptom suffering among adolescents with cancer	11
Abstracts from the 38th Annual Meeting of the Histiocyte Society Held Virtually and In Person in Stockholm, Sweden from September 18‐20, 2022	11
Cutaneous melanoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations	11
Transcranial Doppler screening in Nigerian children with sickle cell disease: A 10‐year longitudinal study on the SPPIBA cohort	11
Race, ethnicity, and socioeconomic differences in incidence of pediatric embryonal tumors in the United States	11
Daratumumab in T‐cell acute lymphoblastic leukaemia: A case report and review of the literature	11
Parental functioning during maintenance treatment for childhood acute lymphoblastic leukemia: Effects of treatment intensity and dexamethasone pulses	11
Parent perceptions of pediatric oncology care during the COVID‐19 pandemic: An Australian study	11
Metastatic rhabdomyosarcoma: Evidence of the impact of radiotherapy on survival. A retrospective single‐center experience	11
Optimizing health literacy to facilitate reproductive health decision‐making in adolescent and young adults with cancer	11
Racial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors	11
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group	11
Daily text message assessments of 6‐mercaptopurine adherence and its proximal contexts in adolescents and young adults with leukemia: A pilot study	11
Idiopathic multicentric Castleman disease with TAFRO clinical subtype responsive to IL‐6/JAK inhibition: A pediatric case series	11
Psychosocial care providers’ perspectives: Barriers to implementing services for siblings of children with cancer	11
Late isolated central nervous system relapse in childhood B‐cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Ch	11
Cognitive functioning, patient health communication, and worry mediate pain predictive effects on health‐related quality of life in youth with sickle cell disease	11
Pancreatoblastoma in children: EXPeRT/PARTNER diagnostic and therapeutic recommendations	11
Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma	11
Multilevel barriers and facilitators of communication in pediatric oncology: A systematic review	11
Nocturnal hypertension associated with stroke and silent cerebral infarcts in children with sickle cell disease	11
Facing the challenges of very rare tumors of pediatric age: The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) background, goals, and achievements	11
Consequences of hemophagocytic lymphohistiocytosis‐like cytokine release syndrome toxicities and concurrent bacteremia	11
A systematic review and meta‐analytic evaluation of psychosocial interventions in parents of children with cancer with an exploratory focus on minority outcomes	11
Real‐world case series and summary of current literature of infants and toddlers with severe hemophilia A with inhibitor on prophylaxis with emicizumab	11
Pyruvate kinase deficiency in children	11
Socioeconomic disparities in survival after high‐risk neuroblastoma treatment with modern therapy	11
Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma	11
Omega 3 fatty acids can reduce early doxorubicin‐induced cardiotoxicity in children with acute lymphoblastic leukemia	11
Effect of time on quality of parent–child communication in pediatric cancer	11
Health support to pediatric cancer survivors and their families during the COVID‐19 pandemic	11
The COVID‐19 pandemic: Distance‐delivered care for childhood cancer survivors	11
Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists’ practice focus: A Sickle Cell Transplant Advocacy and Research	11
Integrating irinotecan in standard chemotherapy: A novel dose‐density combination for high‐risk pediatric sarcomas	11
SARS‐CoV‐2 persistence in immunocompromised children	11
α4β7 Integrin expression and blockade in pediatric and young adult gastrointestinal graft‐versus‐host disease	11
The European Paediatric Rare Tumours Network ‐ European Registry (PARTNER) project for very rare tumors in children	11
Pediatric patients with acute lymphoblastic leukemia treated with blinatumomab in a real‐world setting: Results from the NEUF study	11
Unresectable thoracic neuroblastic tumors: Changes in image‐defined risk factors after chemotherapy and impact on surgical management	11
Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS)	11
Neuropathic pain is associated with poor health‐related quality of life in adolescents with sickle cell disease: A preliminary report	11
Improving self‐management in adolescents with sickle cell disease	11
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high‐risk first relapse B‐cell precursor acute lymphoblastic leukemia	10
Quality assurance in radiation oncology	10
Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children	10
Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group	10
Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS)	10
Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low‐risk clinical trials: A report from the Children's Oncology Group	10
Tumor surveillance for children and adolescents with cancer predisposition syndromes: The psychosocial impact reported by adolescents and caregivers	10
Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia	10
Poor diet quality and adverse eating behaviors in young survivors of childhood cancer	10
Multidisciplinary Network ActiveOncoKids guidelines for providing movement and exercise in pediatric oncology: Consensus‐based recommendations	10
Pain at home during childhood cancer treatment: Severity, prevalence, analgesic use, and interference with daily life	10
SARS‐CoV‐2 vaccine acceptability among caregivers of childhood cancer survivors	10
Incidence and treatment of hemophagocytic lymphohistiocytosis in hospitalized children with Ehrlichia infection	10
Comment on: The COVID‐19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global	10
Prevalence and management of constipation in pediatric acute lymphoblastic leukemia in U.S. children's hospitals	10
In vivo evaluation of the EZH2 inhibitor (EPZ011989) alone or in combination with standard of care cytotoxic agents against pediatric malignant rhabdoid tumor preclinical models—A report from the Pedi	10
“Some things are even worse than telling a child he is going to die”: Pediatric oncology healthcare professionals perspectives on communicating with children about cancer and end of life	10
Cost‐effectiveness of levofloxacin prophylaxis against bacterial infection in pediatric patients with acute myeloid leukemia	10
How we approach Philadelphia chromosome‐positive acute lymphoblastic leukemia in children and young adults	10
Emicizumab in pediatric hemophilia: Bleeding and surgical outcomes from a single‐center retrospective study	10
COVID‐19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York City	10
Immune thrombocytopenia secondary to COVID‐19 infection:  Report of two cases	10
SARS‐CoV‐2‐related multisystem inflammatory syndrome in an immunocompromised child with leukemia	10
Lidocaine infusions and reduced opioid consumption—Retrospective experience in pediatric hematology and oncology patients with refractory pain	10
Coronavirus disease 2019 3 months after hematopoietic stem cell transplant: A pediatric case report	10
Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1‐associated optic pathway gliomas in children	10
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it	10
Systemic viral infection in children receiving chemotherapy for acute leukemia	10